. . . . "An antihemorrhagic (antih\u00E6morrhagic) agent is a substance that promotes hemostasis (stops bleeding). It may also be known as a hemostatic (also spelled haemostatic) agent. Antihemorrhagic agents used in medicine have various mechanisms of action: \n* Systemic drugs work by inhibiting fibrinolysis or promoting coagulation. \n* Locally acting hemostatic agents work by causing vasoconstriction or promoting platelet aggregation."@en . . . . . . . . . . . . . . . . . . . . "8037"^^ . "Anti-hemorr\u00E1gico"@pt . "Gli agente antiemorragici sono sostanze che promuovono l'emostasi (arrestano il sanguinamento). Esso pu\u00F2 anche essere conosciuto come agente emostatico. Un emostatico (in inglese: stiptic) \u00E8 un tipo specifico di agente antiemorragico che lavora formando tessuto per sigillare i vasi sanguigni danneggiati. Le matite emostatiche contengono \"astringenti\". Gli agenti antiemorragici utilizzati in medicina hanno diversi meccanismi d'azione:"@it . . . . "\uC9C0\uD608\uC81C"@ko . . . . "1120572650"^^ . "Gli agente antiemorragici sono sostanze che promuovono l'emostasi (arrestano il sanguinamento). Esso pu\u00F2 anche essere conosciuto come agente emostatico. Un emostatico (in inglese: stiptic) \u00E8 un tipo specifico di agente antiemorragico che lavora formando tessuto per sigillare i vasi sanguigni danneggiati. Le matite emostatiche contengono \"astringenti\". Gli agenti antiemorragici utilizzati in medicina hanno diversi meccanismi d'azione: \n* farmaci sistemici che funzionano inibendo la fibrinolisi o promuovendo la coagulazione; \n* agenti emostatici ad azione locale: lavorano provocando vasocostrizione o promuovendo l'aggregazione piastrinica."@it . . . . "\u041A\u0440\u043E\u0432\u043E\u0441\u043F\u0438\u043D\u043D\u0456 \u0437\u0430\u0441\u043E\u0431\u0438 (\u0433\u0435\u043C\u043E\u0441\u0442\u0430\u0442\u0438\u0447\u043D\u0456 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0438, \u043A\u043E\u0430\u0433\u0443\u043B\u044F\u043D\u0442\u0438, \u0430\u043D\u0442\u0438\u0433\u0435\u043C\u043E\u0440\u0430\u0433\u0456\u0447\u043D\u0456 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0438, \u0436\u0430\u0440\u0433\u043E\u043D\u0456\u0437\u043C: \u0433\u0435\u043C\u043E\u0441\u0442\u0430\u0442\u0438\u043A\u0438) \u2014 \u043B\u0456\u043A\u0438 \u0442\u0430 \u0456\u043D\u0448\u0456 \u0444\u0430\u043A\u0442\u043E\u0440\u0438, \u044F\u043A\u0456 \u043F\u0440\u0438\u0448\u0432\u0438\u0434\u0448\u0443\u044E\u0442\u044C \u043F\u0440\u0438\u0440\u043E\u0434\u043D\u0443 \u0437\u0434\u0430\u0442\u043D\u0456\u0441\u0442\u044C \u043A\u0440\u043E\u0432\u0456 \u0437\u0433\u043E\u0440\u0442\u0430\u0442\u0438\u0441\u044C."@uk . "\u6B62\u8840\u85AC\uFF08hemostatic agent\uFF09\u3068\u306F\u3001\u8840\u7BA1\u58C1\u3084\u8840\u5C0F\u677F\u3001\u8840\u6DB2\u51DD\u56FA\u7CFB\u3001\u7DDA\u6EB6\u7CFB\u306B\u4F5C\u7528\u3057\u3066\u6B62\u8840\u3092\u4FC3\u3059\u85AC\u306E\u7DCF\u79F0\u3067\u3042\u308B\u3002 \u5168\u8EAB\u6295\u4E0E\u85AC\u3068\u3057\u3066\u306F\u30AB\u30EB\u30D0\u30BE\u30AF\u30ED\u30E0\uFF08\u30A2\u30C9\u30CA\u00AE\u306A\u3069\uFF09\u3084\u30A2\u30C9\u30EC\u30CE\u30AF\u30ED\u30E0\u30E2\u30CE\u30A2\u30DF\u30CE\u30B0\u30A2\u30CB\u30B8\u30F3\uFF08S\u30FB\u30A2\u30C9\u30AF\u30CE\u30F3\u00AE\u306A\u3069\uFF09\u3001\u30C8\u30E9\u30CD\u30AD\u30B5\u30E0\u9178\uFF08\u30C8\u30E9\u30F3\u30B5\u30DF\u30F3\u00AE\u306A\u3069\uFF09\u3001\uFF08\u30EC\u30D7\u30C1\u30E9\u30FC\u30BC\u00AE\uFF09\u3068\u3044\u3063\u305F\u85AC\u304C\u77E5\u3089\u308C\u3066\u3044\u308B\u3002\u307E\u305F\u5C40\u6240\u6295\u4E0E\u85AC\u3068\u3057\u3066\u306F\u30C8\u30ED\u30F3\u30D3\u30F3\u3084\u30A2\u30C9\u30EC\u30CA\u30EA\u30F3\u306A\u3069\u304C\u77E5\u3089\u308C\u3066\u3044\u308B\u3002"@ja . "Um anti-hemorr\u00E1gico \u00E9 uma subst\u00E2ncia que promove a hemostasia (processo que p\u00E1ra o sangramento). Tamb\u00E9m pode ser conhecido como um agente hemost\u00E1tico. Os agentes anti-hemorr\u00E1gicos usados na medicina t\u00EAm v\u00E1rios mecanismos de a\u00E7\u00E3o: \n* drogas sist\u00EAmicas que funcionam inibindo a fibrin\u00F3lise ou promovem a coagula\u00E7\u00E3o. \n* agentes hemost\u00E1ticos de a\u00E7\u00E3o local, causando vasoconstri\u00E7\u00E3o ou promovendo a agrega\u00E7\u00E3o plaquet\u00E1ria."@pt . . . . "Antiemorragici"@it . . . "H\u00E4mostatikum"@de . . . . . "\uC9C0\uD608\uC81C(\u6B62\u8840\u5291)\uB294 \uCD9C\uD608\uC99D\uC0C1\uC744 \uBA48\uCD94\uAC8C \uD558\uB3C4\uB85D \uC4F0\uC774\uB294 \uC57D\uC774\uB2E4."@ko . . . . . . . . . "Ein H\u00E4mostatikum (altgriechisch \u03B1\u1F37\u03BC\u03B1 ha\u00EDma \u201EBlut\u201C und \u03C3\u03C4\u03AC\u03C3\u03B9\u03C2 st\u00E1sis \u201E[Still-]Stand\u201C) ist eine Substanz, die zur Blutstillung angewendet wird. Weitere Synonyme sind H\u00E4matostatikum, Styptikum, H\u00E4mostyptikum oder auch H\u00E4matostyptikum. Die Bezeichnung Antih\u00E4morrhagikum (griechisch \u1F00\u03BD\u03C4\u03AF anti \u201Egegen\u201C; \u1FE5\u03B1\u03B3\u03AE rhag\u1E17 \u201Edas Aufbrechen, Rei\u00DFen\u201C) stellt einen zusammenfassenden, nicht eindeutig definierten Begriff dar. Gemeint sind dabei Mittel, die die Gerinnungsf\u00E4higkeit des Blutes steigern: \n* Gerinnungsfaktoren (z. B. Faktor VIII bei H\u00E4mophilie A oder Faktor IX bei H\u00E4mophilie B, Von-Willebrand-Faktor bei Willebrand-J\u00FCrgens-Syndrom) \n* Desmopressin (z. B. bei ASS-Einnahme zur Verbesserung der Funktion der Blutpl\u00E4ttchen) \n* 4-(Aminomethyl)benzoes\u00E4ure steigert die Verklumpung der Blutpl\u00E4ttchen mit Fibrin \n* Thrombozytenkonzentrate: enthalten Blutpl\u00E4ttchen, z. B. bei starken Verbrennungen/Verletzungen \n* Protamin: Medikament, das Heparin, ein verbreitetes Antikoagulans, neutralisiert \n* Vitamin K1, eingesetzt zur Neutralisierung von Cumarinen (Antidot) \n* Eisen-III-Chlorid historisch als Blutstiller Das Gegenst\u00FCck, also Medikamente zur Hemmung der Blutgerinnung, sind Antikoagulanzien."@de . "\u6B62\u8840\u85AC"@ja . . . . . . . . . "\u041A\u0440\u043E\u0432\u043E\u0441\u043F\u0438\u043D\u043D\u0456 \u0437\u0430\u0441\u043E\u0431\u0438 (\u0433\u0435\u043C\u043E\u0441\u0442\u0430\u0442\u0438\u0447\u043D\u0456 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0438, \u043A\u043E\u0430\u0433\u0443\u043B\u044F\u043D\u0442\u0438, \u0430\u043D\u0442\u0438\u0433\u0435\u043C\u043E\u0440\u0430\u0433\u0456\u0447\u043D\u0456 \u043F\u0440\u0435\u043F\u0430\u0440\u0430\u0442\u0438, \u0436\u0430\u0440\u0433\u043E\u043D\u0456\u0437\u043C: \u0433\u0435\u043C\u043E\u0441\u0442\u0430\u0442\u0438\u043A\u0438) \u2014 \u043B\u0456\u043A\u0438 \u0442\u0430 \u0456\u043D\u0448\u0456 \u0444\u0430\u043A\u0442\u043E\u0440\u0438, \u044F\u043A\u0456 \u043F\u0440\u0438\u0448\u0432\u0438\u0434\u0448\u0443\u044E\u0442\u044C \u043F\u0440\u0438\u0440\u043E\u0434\u043D\u0443 \u0437\u0434\u0430\u0442\u043D\u0456\u0441\u0442\u044C \u043A\u0440\u043E\u0432\u0456 \u0437\u0433\u043E\u0440\u0442\u0430\u0442\u0438\u0441\u044C."@uk . . . . . . . "\uC9C0\uD608\uC81C(\u6B62\u8840\u5291)\uB294 \uCD9C\uD608\uC99D\uC0C1\uC744 \uBA48\uCD94\uAC8C \uD558\uB3C4\uB85D \uC4F0\uC774\uB294 \uC57D\uC774\uB2E4."@ko . . . . . . . . . . . "An antihemorrhagic (antih\u00E6morrhagic) agent is a substance that promotes hemostasis (stops bleeding). It may also be known as a hemostatic (also spelled haemostatic) agent. Antihemorrhagic agents used in medicine have various mechanisms of action: \n* Systemic drugs work by inhibiting fibrinolysis or promoting coagulation. \n* Locally acting hemostatic agents work by causing vasoconstriction or promoting platelet aggregation."@en . "Antihemorrhagic"@en . . . . . "2090492"^^ . "\u6B62\u8840\u85AC\uFF08hemostatic agent\uFF09\u3068\u306F\u3001\u8840\u7BA1\u58C1\u3084\u8840\u5C0F\u677F\u3001\u8840\u6DB2\u51DD\u56FA\u7CFB\u3001\u7DDA\u6EB6\u7CFB\u306B\u4F5C\u7528\u3057\u3066\u6B62\u8840\u3092\u4FC3\u3059\u85AC\u306E\u7DCF\u79F0\u3067\u3042\u308B\u3002 \u5168\u8EAB\u6295\u4E0E\u85AC\u3068\u3057\u3066\u306F\u30AB\u30EB\u30D0\u30BE\u30AF\u30ED\u30E0\uFF08\u30A2\u30C9\u30CA\u00AE\u306A\u3069\uFF09\u3084\u30A2\u30C9\u30EC\u30CE\u30AF\u30ED\u30E0\u30E2\u30CE\u30A2\u30DF\u30CE\u30B0\u30A2\u30CB\u30B8\u30F3\uFF08S\u30FB\u30A2\u30C9\u30AF\u30CE\u30F3\u00AE\u306A\u3069\uFF09\u3001\u30C8\u30E9\u30CD\u30AD\u30B5\u30E0\u9178\uFF08\u30C8\u30E9\u30F3\u30B5\u30DF\u30F3\u00AE\u306A\u3069\uFF09\u3001\uFF08\u30EC\u30D7\u30C1\u30E9\u30FC\u30BC\u00AE\uFF09\u3068\u3044\u3063\u305F\u85AC\u304C\u77E5\u3089\u308C\u3066\u3044\u308B\u3002\u307E\u305F\u5C40\u6240\u6295\u4E0E\u85AC\u3068\u3057\u3066\u306F\u30C8\u30ED\u30F3\u30D3\u30F3\u3084\u30A2\u30C9\u30EC\u30CA\u30EA\u30F3\u306A\u3069\u304C\u77E5\u3089\u308C\u3066\u3044\u308B\u3002"@ja . . "\u041A\u0440\u043E\u0432\u043E\u0441\u043F\u0438\u043D\u043D\u0456 \u0437\u0430\u0441\u043E\u0431\u0438"@uk . . "Ein H\u00E4mostatikum (altgriechisch \u03B1\u1F37\u03BC\u03B1 ha\u00EDma \u201EBlut\u201C und \u03C3\u03C4\u03AC\u03C3\u03B9\u03C2 st\u00E1sis \u201E[Still-]Stand\u201C) ist eine Substanz, die zur Blutstillung angewendet wird. Weitere Synonyme sind H\u00E4matostatikum, Styptikum, H\u00E4mostyptikum oder auch H\u00E4matostyptikum. Die Bezeichnung Antih\u00E4morrhagikum (griechisch \u1F00\u03BD\u03C4\u03AF anti \u201Egegen\u201C; \u1FE5\u03B1\u03B3\u03AE rhag\u1E17 \u201Edas Aufbrechen, Rei\u00DFen\u201C) stellt einen zusammenfassenden, nicht eindeutig definierten Begriff dar. Gemeint sind dabei Mittel, die die Gerinnungsf\u00E4higkeit des Blutes steigern: Das Gegenst\u00FCck, also Medikamente zur Hemmung der Blutgerinnung, sind Antikoagulanzien."@de . . "Um anti-hemorr\u00E1gico \u00E9 uma subst\u00E2ncia que promove a hemostasia (processo que p\u00E1ra o sangramento). Tamb\u00E9m pode ser conhecido como um agente hemost\u00E1tico. Os agentes anti-hemorr\u00E1gicos usados na medicina t\u00EAm v\u00E1rios mecanismos de a\u00E7\u00E3o: \n* drogas sist\u00EAmicas que funcionam inibindo a fibrin\u00F3lise ou promovem a coagula\u00E7\u00E3o. \n* agentes hemost\u00E1ticos de a\u00E7\u00E3o local, causando vasoconstri\u00E7\u00E3o ou promovendo a agrega\u00E7\u00E3o plaquet\u00E1ria."@pt . .